ProBio

📣 Pleased to share the publication of the ProBio-mHSPC trial protocol in @EUplatinum Focus: a ctDNA-driven platform trial designed to personalize treatment intensity for patients with metastatic hormone-sensitive prostate cancer.

📣 Published in @EUplatinum : our Letter to the Editor on the @myESMO Clinical Practice Guideline for advanced and metastatic prostate cancer.

⚕️The guideline notes the lack of mCRPC trials comparing ARPI with docetaxel-based chemotherapy

🌐doi.org/10.1016/j.euru…

🚨 New Study Alert! 🚨

What if a blood test 🩸 could infer prognosis in advanced prostate cancer? Our latest #ProBio trial study reveals the prognostic power of circulating tumor DNA (ctDNA) 🧬 in #mCRPC

A thread 🧵👇 #CancerResearch #ProstateCancer

[1/8]

Meet the @ProBioTrial consortium: healthcare professionals from 🇸🇪🇧🇪🇳🇴🇨🇭specialised in the treatment of men with metastatic #ProstateCancer

They made the 🥈#ProBioTrial International Investigator’s Meeting a success 🙏

Presentations soon available on probiotrial.org

Prof. Henrik Grönberg opening the 2nd #ProBioTrial International Investigators Meeting in Stockholm! 🌍

Healthcare professionals from 🇸🇪 🇧🇪 🇳🇴 🇨🇭 are coming together to push the boundaries of #ProstateCancer cancer research and treatment.

Let’s make an impact! 💪